Adjuvant therapy of non small-cell lung cancer.
Multiple randomized prospective trials have failed to show a definitive survival advantage for the administration of adjuvant therapy following complete resection of non small-cell lung cancer.
Keller
S M
SM
Division of Thoracic Surgery, The Beth Israel Medical Center, New York, New York 10003, USA. skeller@bethisraelny.org